Breast Cancer Clinical Trial
Diabetes Care for Breast Cancer Patients
Summary
The goal of this study is to find a new way to make diabetes care better for patients with breast cancer and diabetes who are currently receiving chemotherapy treatment. We will have two groups, the researchers will decide who is in which group. One group will be working with a nurse who is trained in diabetes care while the other does not. This will allow the investigators to see if having a trained nurse as part of the care team can help improve the care the patients receive.
Full Description
The present study aims to develop a stakeholder-engaged nurse practitioner (NP)-led intervention to improve diabetes care for patients with breast cancer and diabetes who are ongoing chemotherapy.
This is a pilot feasibility study, in which we will use a quasi-experimental pre-post design with non-randomized intervention and control groups. In this feasibility study, the investigators will first enroll 38 eligible patients for the control group and collect effectiveness measures at baseline and follow-up (end of chemotherapy, ~12 weeks). Through chart review, the investigators will document chemotherapy regimen completion at follow-up. The investigators will then enroll 38 patients for the intervention group, collecting the effectiveness and implementation outcomes at the end of chemotherapy (~12 weeks).
The main hypothesis that will be tested in this pilot study is that a nurse practitioner embedded in the oncology team who is trained in diabetes management may successfully manage diabetes during active breast cancer care for patients undergoing chemotherapy.
Eligibility Criteria
Inclusion Criteria:
Newly diagnosed invasive breast cancer
Plan to receive neo-adjuvant or adjuvant chemotherapy at Weill Cornell Medicine (WCM)
Age 18+ years
Pre-diabetes OR type 2 diabetes. Treatment with antidiabetic medication OR
HbA1c greater than or equal to 5.7 OR
Random glucose greater than or equal to OR
Fasting blood glucose greater than or equal to 100
Exclusion Criteria:
Patients receiving hospice care
Type 1 diabetes
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Brooklyn New York, 11215, United States More Info
Principal Investigator
Flushing New York, 11355, United States More Info
Principal Investigator
New York New York, 10021, United States More Info
Principal Investigator
How clear is this clinincal trial information?